TerraPower develops advanced nuclear technologies to provide carbon-free energy and medical isotopes. The company works on next-generation reactors such as the Traveling Wave Reactor, Molten Chloride Fast Reactor, and sodium fast reactor. Its products generate electricity through fission in these next-gen designs, and the medical isotope work involves extracting isotopes like Actinium-225 for cancer treatment via partnerships (e.g., with Radiopharm). TerraPower generates revenue through technology licensing, partnerships, and supply agreements, serving utilities, government agencies, and medical institutions. The company differentiates itself by pursuing a diverse portfolio of reactor technologies and by combining power generation with medical isotope applications, complemented by collaborations and licensing to bring technologies to market. Its goal is to provide scalable, carbon-free energy while addressing medical needs through isotope production and new reactor deployments.
Company Size
1,001-5,000
Company Stage
Late Stage VC
Total Funding
$1.6B
Headquarters
Bellevue, Washington
Founded
2008
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?